Graphical Glimpse 32
Experimentelle Kopf-Hals-Onkologie 2

Programme

• 15:00 – 15:05 3 Min. 2 Min.

  • Visual Abstract

  Targeted therapy with the antibody-drug conjugate sacituzumab-govitecan as a promising treatment strategy for head and neck squamous cell carcinoma

  • Alexander Philippe Maas (Köln)

   Experimentelle Onkologie, Kopf-Hals-Onkologie
• 15:05 – 15:10 3 Min. 2 Min.

  • Visual Abstract

  Cal27-derived Exosomes for site-specific Immunomodulation of natural killer cells in head and neck Squamous Cell Carcinoma

  • Veena Ramesh (München)

   Experimentelle Onkologie, Kopf-Hals-Onkologie
• 15:10 – 15:15 3 Min. 2 Min.

  • Visual Abstract

  Bioenergetic depression in platelets of Head and Neck cancer patients

  • Madeleine Mogl (München)

   Kopf-Hals-Onkologie, Tumormarker
• 15:15 – 15:20 3 Min. 2 Min.

  • Visual Abstract

  Unveiling the prognostic role of IFNAR signaling in neutrophils in HNC

  • Pouya Elahi (Essen)

   Experimentelle Onkologie, Kopf-Hals-Onkologie
• 15:20 – 15:25 3 Min. 2 Min.

  • Visual Abstract

  Temporary tumor cell reverse migration through EGFR stimulation: potential implications for HNSCC therapy

  • Christin Geissler (Frankfurt a. M.)

   Experimentelle Onkologie, Kopf-Hals-Onkologie
• 15:25 – 15:30 3 Min. 2 Min.

  • Visual Abstract

  Development of in vitro and ex vivo models for testing of new therapeutic options in HNSCC

  • Ines Ugele (Regensburg)

   Experimentelle Onkologie, Kopf-Hals-Onkologie
• 15:30 – 15:35 3 Min. 2 Min.

  • Visual Abstract

  Protein cargo and functional properties of salivary exosomes from head and neck cancer patients are stage dependent

  • Julia Schütz (Mannheim)

   Experimentelle Onkologie, Kopf-Hals-Onkologie
• 15:35 – 15:40 3 Min. 2 Min.

  • Visual Abstract

  Characterization and functional analysis of exosomes derived from the supernatant of head and neck cancer cells: Implications for Immunomodulation

  • Khouloud Hachani (München)

   Experimentelle Onkologie, Kopf-Hals-Onkologie
• 15:40 – 15:45 3 Min. 2 Min.

  • Visual Abstract

  Development of anti-mHsp70 CAR cells targeting HNSCC tumors

  • Anskar Trill (München)

   Experimentelle Onkologie, Kopf-Hals-Onkologie
• 15:45 – 15:50 3 Min. 2 Min.

  • Visual Abstract

  Tumour–associated inflammation in patients with advanced and relapsing hypopharyngeal carcinoma

  • Anna-Rebekka Staufenberg (Mainz)

   Klinische Studien / Immunonkologie, Kopf-Hals-Onkologie
• 15:50 – 15:55 3 Min. 2 Min.

  • Visual Abstract

  Turning Neutrophils into guardians: Targeting neutrophil STAT3 signaling impairs tumor growth via the modulation of their anti-tumor bias

  • Irem Özel (Essen)

   Experimentelle Onkologie, Kopf-Hals-Onkologie
• 15:55 – 16:00 3 Min. 2 Min.

  • Visual Abstract

  Addressing the Three R principle in microvascular research – Measurements of Vascular development and proangiogenic factors with the HET cam assay

  • Jonas Eckrich (Mainz)

   Experimentelle Onkologie, Kopf-Hals-Onkologie
• 16:00 – 16:05 3 Min. 2 Min.

  • Visual Abstract

  Immunomodulating effects of tumor-educated platelet derived exosomes and plasma exosomes of HNSCC patients

  • Kathrin Werner (München)

   Experimentelle Onkologie, Kopf-Hals-Onkologie
• 16:05 – 16:10 3 Min. 2 Min.

  • Visual Abstract

  Interaction between Neutrophil Granulocytes and tumor cells based on head and neck Carcinoma

  • Andreas Froschermaier (München)

   Experimentelle Onkologie, Kopf-Hals-Onkologie
• 16:10 – 16:15 3 Min. 2 Min.

  • Visual Abstract

  Comparing nanocellulose (NC)-based vs gelatin methacrylate (GelMA) bioink for fabricating a 3D bioprinted head and neck squamous cell carcinoma (HNSCC) model

  • Alexya Azhakesan (Mannheim)

  

   Biomaterialien / Tissue Engineering / Stammzellen, Sonstiges